Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02827695 · ClinicalTrials.gov registry record · NA
Smart Phone Medication Adherence Saves Kidneys--SMASK
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02827695 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 80 participants.
The verdict
NCT02827695, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Investigators will employ a 2-arm Randomized Controlled Trial (RCT) design with the subject as the unit of randomization and analysis. Kidney transplant recipients having uncontrolled hypertension will be enrolled into a screening phase to measure medication non-adherence. Each subject will use an electronic pill tray for 1 month without any reminder functions activated. Non-adherent subjects who remain uncontrolled will be randomly assigned to SMASK or Standard Care (SC). SC will continue to use the pill tray with reminders turned off and will receive attention control texts with healthy lifestyle information. SMASK will have the reminder functions of the electronic pill tray activated and will receive a Bluetooth blood pressure monitor and an app to collect the data and send to researchers. Subjects in the second phase will participate in 4 more evaluations at months 1, 3, 6, 12 post randomization. Research staff will measure resting blood pressure and heart rate.
Interventions
- BEHAVIORAL SMASK
- BEHAVIORAL EnhancedSC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02827695
The ClinicalTrials.gov registry entry for NCT02827695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMASK is the first listed.
NCT02827695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02827695 about?
NCT02827695 is a clinical study titled "Smart Phone Medication Adherence Saves Kidneys--SMASK". Investigators will employ a 2-arm Randomized Controlled Trial (RCT) design with the subject as the unit of randomization and analysis. Kidney transplant recipients having uncontrolled hypertension will be enrolled into a screening phase to measure medication non-adherence. Each subject will use an e...
What is the current status of trial NCT02827695?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-05. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT02827695?
The interventions under investigation include: SMASK (BEHAVIORAL), EnhancedSC (BEHAVIORAL).
Who is sponsoring clinical trial NCT02827695?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.